For example, a pan-cancer analysis of CLDN6 showed it is minimally expressed in most normal adult tissues but activated in several cancers (germ cell tumors, gynecologic cancers), correlating with worse outcomes (104). This evidence concerns the gene CLDN6 and testicular germ cell tumor.